The Link Between IgA Nephropathy and Celiac Disease

Scientists have identified common molecular pathways in IgA nephropathy and celiac disease. Both conditions involve dysregulated immune responses and IgA deposits. However, the exact genetic link remained a mystery for years. Recent research now highlights a strong gut-kidney axis. This connection suggests that intestinal inflammation directly impacts kidney health. Consequently, clinicians must consider the presence of both disorders in symptomatic patients.

Shared Biomarkers: ITGB2, CD74, and KLK1

The study utilized transcriptomic analysis and machine learning to find shared hub genes. Researchers pinpointed ITGB2, CD74, and KLK1 as the primary biomarkers. Specifically, these three genes demonstrate exceptional diagnostic accuracy. A combined model using these markers achieved an area under the curve (AUC) of 0.9. Furthermore, single-cell RNA sequencing confirmed their specific roles in immune cells. These genes contribute to disease progression and immune dysregulation in both IgA nephropathy and celiac disease.

In addition to diagnostics, the research predicted four candidate therapeutic agents. These drugs might offer new ways to stabilize the immune system. Collectively, these findings provide fresh insights into pathogenesis. They also suggest that targeted therapies could treat both conditions simultaneously.

FAQs

Can celiac disease cause IgA nephropathy?

While celiac disease does not directly cause IgA nephropathy, they share similar immune triggers. Patients with celiac disease have a higher risk of developing IgA deposits in the kidneys due to the gut-kidney axis.

What are the benefits of the new biomarkers?

The biomarkers ITGB2, CD74, and KLK1 help doctors diagnose both conditions more accurately. They also provide potential targets for future drug development.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Tao S et al. The shared mechanisms and potential diagnostic markers for IgA nephropathy and celiac disease. Autoimmunity. 2026 Dec 31. doi: 10.1080/08916934.2026.2635179. PMID: 41714845.


2. Abbad L, et al. Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation. Front Med (Lausanne). 2022 Nov 16;9:1033100. doi: 10.3389/fmed.2022.1033100.


3. Welander A, et al. Increased risk of IgA Nephropathy among individuals with celiac disease. J Clin Gastroenterol. 2013;47:678-683. doi: 10.1097/MCG.0b013e31828f4e7c.